Tender Details

Country: USA
Summary: Notice of Intent to Award a Sole Source - CBER Biologics Effectiveness and Safety (BEST) BEST1 Initiative: BEST Coordinating Center
UST Ref No: 123102143
Deadline: 04 Aug 2025
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: Refer Document
Notice Type: Tender
Document Ref. No.: NOI_SS_CBER-2025-126923
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
Description
The U.S. Food and Drug Administration (FDA) intends to solicit a 12-month base year, plus three (3) four-month option periods, sole source, time-and-materials type contract from Acumen LLC; 500 Airport Blvd., Suite 100; Burlingame, CA 94010, in accordance with the authority under Federal Acquisition Regulation (FAR) 6.302-1 - Only one responsible source and no other supplies or services will satisfy agency requirements, and 15.101 Contracting by Negotiation. The North American Industry Classification System (NAICS) code is 518210 - Data Processing, Hosting, and Related Services. The anticipated period of performance consists of a 12-month base year, plus three (3) four-month option periods.This acquisition is for a short-term, sole-source bridge contract to Acumen, LLC, the incumbent Coordinating Center for the Biologics Effectiveness and Safety (BEST) Initiative, which supports post market active surveillance of biologics. The bridge contract will enable continuation of mission-critical operations during the transition to a new and fully competed contract, which is currently in the planning phase.
This notice is not a request for competitive proposals. However, any party that believes it is capable of meeting the requirements as stated herein may submit a written response which clearly supports and demonstrates its ability to perform the requirements. Any response must be received by the response date and time set forth in this notice. Any response will undergo a review to determine whether the respondent can meet the contract requirements. A determination by the Government whether to compete this proposed requirement based upon responses to this notice is solely within the discretion of the Government.Response Date and Time: 4:00 p.m. ET on August 4, 2025. Responses must be emailed to maevexavier@fda.hhs.gov, with a CC: to james.jenretteiii@fda.hhs.gov.
Documents:

Intent-to-Sole-Source-Acumen-LLC-BEST1.pdf

If you are registered member, kindly login to view full details of this tender notice:

Notice of Intent to Award a Sole Source - CBER Biologics Effectiveness and Safety (BEST) BEST1 Initiative: BEST Coordinating Center - USA Tender

The HEALTH AND HUMAN SERVICES, DEPARTMENT OF | FOOD AND DRUG ADMINISTRATION, a Government sector organization in USA, has announced a new tender for Notice of Intent to Award a Sole Source - CBER Biologics Effectiveness and Safety (BEST) BEST1 Initiative: BEST Coordinating Center. This tender is published on USARFP under UST Ref No: 123102143 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-08-04.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.